MIRA Pharmaceuticals Inc./$MIRA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
Ticker
$MIRA
Sector
Primary listing
Employees
-
Headquarters
Website
MIRA Metrics
BasicAdvanced
$27M
-
-$0.46
1.79
-
Price and volume
Market cap
$27M
Beta
1.79
52-week high
$2.09
52-week low
$0.73
Average daily volume
1.1M
Financial strength
Current ratio
2.791
Quick ratio
2.447
Profitability
Management effectiveness
Return on assets (TTM)
-253.31%
Return on equity (TTM)
-556.87%
Valuation
Price to book
43.63
Price to tangible book (TTM)
43.63
Price to free cash flow (TTM)
-3.938
Free cash flow yield (TTM)
-25.39%
Free cash flow per share (TTM)
-0.363
Growth
Earnings per share change (TTM)
-46.79%
MIRA News
AllArticlesVideos
MIRA Pharmaceuticals Announces Completion of Phase 1 Single Ascending Dose for Oral Ketamir-2 with No Safety Concerns, Advances to Multiple Ascending Dose Stage
Accesswire·7 days ago
MIRA Pharmaceuticals' Second Ketamir-2 Manuscript Accepted for Peer-Reviewed Publication Demonstrating Superior Efficacy in Preclinical Neuropathic Pain Models Versus Ketamine, Gabapentin, or Pregabalin
Accesswire·2 weeks ago
MIRA Pharmaceuticals Reports New Topical Ketamir-2 shows comparable effects to Injected Morphine in Preclinical Pain Study
Accesswire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for MIRA Pharmaceuticals Inc. stock?
MIRA Pharmaceuticals Inc. (MIRA) has a market cap of $27M as of August 26, 2025.
What is the P/E ratio for MIRA Pharmaceuticals Inc. stock?
The price to earnings (P/E) ratio for MIRA Pharmaceuticals Inc. (MIRA) stock is 0 as of August 26, 2025.
Does MIRA Pharmaceuticals Inc. stock pay dividends?
No, MIRA Pharmaceuticals Inc. (MIRA) stock does not pay dividends to its shareholders as of August 26, 2025.
When is the next MIRA Pharmaceuticals Inc. dividend payment date?
MIRA Pharmaceuticals Inc. (MIRA) stock does not pay dividends to its shareholders.
What is the beta indicator for MIRA Pharmaceuticals Inc.?
MIRA Pharmaceuticals Inc. (MIRA) has a beta rating of 1.79. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.